[Ferlay J, Parkin DM, Steliarova-Foucher E. Estimates of cancer incidence and mortality in Europe in 2008. Eur J Cancer. 2010; 46(4): 765-781.10.1016/j.ejca.2009.12.01420116997]Search in Google Scholar
[Lung cancer incidence and mortality worldwide in 2008. Summary. ( http://globocan.iarc.fr/factsheets/cancers/lung.asp]Search in Google Scholar
[Lonardo F, Li X, Kaplun A, Soubani A, Sethi S, Gadgeel S, Sheng S. The natural tumor suppressor protein maspin and potential application in non small cell lung cancer. Curr Pharm Des. 2010; 16(16): 1877-1881.10.2174/138161210791208974290849520337574]Search in Google Scholar
[Sculier JP, Chansky K, Crowley JJ, Van Meerbeeck J, Goldstraw P; International Staging Committee and Participating Institutions. The impact of additional prognostic factors on survival and their relationship with the anatomical extent of disease expressed by the 6th Edition of the TNM Classification of Malignant Tumors and the proposals for the 7th Edition. J Thorac Oncol. 2008; 3(5): 457-466.10.1097/JTO.0b013e31816de2b818448996]Search in Google Scholar
[Valerianova ZG, Vukov MI, Dimitrova NE, Eds. Cancer Incidence in Bulgaria 2006, 1st ed. Sofia: AVIS-24 Ltd, 2008.]Search in Google Scholar
[Zochbauer-Muller S, Gazdar AF, Minna JD. Molecular pathogenesis of lung cancer. Annu Rev Physiol. 2002; 64: 681-708.10.1146/annurev.physiol.64.081501.15582811826285]Search in Google Scholar
[Pignon JP, Tribodet H, Scagliotti GV, Douillard JY, Shepherd FA, Stephens RJ, Dunant A, Torri V, Rosell R, Seymour L, Spiro SG, Rolland E, Fossati R, Aubert D, Ding K, Waller D, Le Chevalier T; LACE Collaborative Group. Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE Collaborative Group. J Clin Oncol. 2008; 26(21): 3552-3559.10.1200/JCO.2007.13.903018506026]Search in Google Scholar
[Goldstraw P, Crowley J, Chansky K, Giroux DJ, Groome PA, Rami-Porta R, Postmus PE, Rusch V, Sobin L; International Association for the Study of Lung Cancer International Staging Committee; Participating Institutions. The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumours. J Thorac Oncol. 2007; 2(8): 706-714.10.1097/JTO.0b013e31812f3c1a17762336]Search in Google Scholar
[Fulda S. Tumor resistance to apoptosis. Int J Cancer. 2009; 124(3): 511-515.10.1002/ijc.2406419003982]Search in Google Scholar
[Horn L, Sandler A. Epidermal growth factor receptor inhibitors and antiangiogenic agents for the treatment of non-small cell lung cancer. Clin Cancer Res. 2009; 15(16): 5040-5048.10.1158/1078-0432.CCR-09-0520352818219671872]Search in Google Scholar
[Schulz WA. Apoptosis and replicative senescence in cancer. In: Schulz WA, Ed. Molecular Biology of Human Cancers. Dordrecht: Springer Science + Business Media. 2005: 145.]Search in Google Scholar
[Kang BN, Ahmad AS, Saleem S, Patterson RL, Hester L, Doré S, Snyder SH. Death-associated protein kinase-mediated cell death modulated by interaction with DANGER. J Neurosci. 2010; 30(1): 93-98.10.1523/JNEUROSCI.3974-09.2010284072020053891]Search in Google Scholar
[Jang CW, Chen CH, Chen CC, Chen J, Su YH, Chen RH. TGF-beta induces apoptosis through Smad-mediated expression of DAP-kinase. Nature Cell Biol. 2001; 4(1): 51-58.10.1038/ncb73111740493]Search in Google Scholar
[Mashkova TD, Oparina NIu, Zinov'eva OL, Kropotova ES, Dubovaia VI, Poltaraus AB, Fridman MV, Kopantsev EP, Vinogradova TV, Zinov'eva MV, Laktionov KK, Kasymova OT, Zborovskaia IB, Sverdlov ED, Kiselev LL. Transcription TIMP3, DAPk1 and AKR1B10 genes in squamous cell lung cancer. Mol Biol (Mosk). 2006; 40(6): 1047-1054.10.1134/S002689330606014817209422]Search in Google Scholar
[Han W, Wang T, Reilly AA, Keller SM, Spivack SD. Gene promoter methylation assayed in exhaled breath, with differences in smokers and lung cancer patients. Respir Res. 2009; 10: 86.10.1186/1465-9921-10-86275991619781081]Search in Google Scholar
[Wang Y, Zhang D, Zheng W, Luo J, Bai Y, Lu Z. Multiple gene methylation of nonsmall cell lung cancers evaluated with 3-dimensional microarray. Cancer. 2008; 112(6): 1325-1336.10.1002/cncr.2331218286531]Search in Google Scholar
[Liu Y, Gao W, Siegfried JM, Weissfeld JL, Luketich JD, Keohavong P. Promoter methylation of RASSF1A and DAPK and mutations of K-ras, p53, and EGFR in lung tumors from smokers and never-smokers. BMC Cancer. 2007; 7: 74.10.1186/1471-2407-7-74187781217477876]Search in Google Scholar
[Logue SE, Martin SJ. Caspase activation cascades in apoptosis. Biochem Soc Trans. 2008; 36(Pt. 1): 1-9.10.1042/BST036000118208375]Search in Google Scholar
[Neumann L, Pforr C, Beaudouin J, Pappa A, Fricker N, Krammer PH, Lavrik IN, Eils R. Dynamics within the CD95 death-inducing signaling complex decide life and death of cells. Mol Syst Biol. 2010; 6: 352.10.1038/msb.2010.6285844220212524]Search in Google Scholar
[Yang Q, Kiernan CM, Tian Y, Salwen HR, Chlenski A, Brumback BA, London WB, Cohn SL. Methylation of CASP8, DCR2, and HIN-1 in neuroblastoma is associated with poor outcome. Clin Cancer Res. 2007; 13(11): 3191-3197.10.1158/1078-0432.CCR-06-284617545522]Search in Google Scholar
[Stupack DG, Teitz T, Potter MD, Mikolon D, Houghton PJ, Kidd VJ, Lahti JM, Cheresh DA. Potentiation of neuroblastoma metastasis by loss of caspase-8. Nature. 2006; 439(7072): 95-99.10.1038/nature0432316397500]Search in Google Scholar
[Su H, Bidere N, Zheng L, Cubre A, Sakai K, Dale J, Salmena L, Hakem R, Straus S, Lenardo M. Requirement for caspase-8 in NF-kappa-B activation by antigen receptor. Science. 2005; 307(5714): 1465-1468.10.1126/science.110476515746428]Search in Google Scholar
[Bae J, Leo CP, Hsu SY, Hsueh AJW. MCL1S, a splicing variant of the antiapoptotic BCL-2 family member MCL-1, encodes a proapoptotic protein possessing only the BH3 domain. J Biol Chem. 2000; 275(33): 25255-25261.10.1074/jbc.M90982619910837489]Search in Google Scholar